Must have experience with: Leading analytics and market research initiatives targeting healthcare providers, patients, caregivers, payers, and other critical stakeholders; Data Mining of syndicated pharma data sources such as IQVIA, Komodo, and MMIT to analytically derive insights to inform Business Questions and Key decisions; Assessing and implementing novel methodologies and frameworks that address rare disease challenges, such as identifying meaningful insights for rare disease patient journeys, improving diagnostic pathways, and enhancing brand differentiation throughout the product lifecycle; Developing and operationalizing diagnostic funnel and patient journey models specific to rare disease indications, focusing on the unique challenges of disease awareness, diagnosis, and treatment pathways; Coding in SQL, Python, R and/or SAS (BASE, STAT, SQL, or Macros) in cloud-based data platforms such as Snowflake; Hands-on Working Knowledge of Business Reporting Intelligence tools such as Tableau, PowerBI, and MicroStrategy to report Brand Performance and Execution Metrics in Rare Disease Space; Applying Artificial Intelligence and Machine Learning Based models on top of De-identified Patient and Physician datasets such as Claims, and EMR for Patient Identification, Customer Targeting, Leads and Triggers Generation, and Customer Insights; Conducting Primary Market Research Studies in Rare Disease Space to inform Clinical Message Effectiveness and Brand - Performance, Positioning, Perceptions, Access, and Treatment related questions; Working on Commercial Mix Modelling, Field Alignment, Incentive Compensation and Call Planning to Design Sales Force Commercial Effectiveness Strategy; Major CRM Tools such as Veeva and Salesforce, and leveraging them to develop key capabilities for Omnichannel Engagement Strategy; and Developing Analytics Framework for New Product Launches working with different stakeholders in Commercial Organization. Regeneron Healthcare Solutions, Inc. seeks an Associate Director Business Analysis (Sleepy Hollow, NY) to support the Rare Disease Commercial Business Unit through the application of end-to-end analyses and insights, and the application of analytical expertise to drive strategic choices, tactical execution, and commercial excellence.